Archives of Clinical Infectious Diseases

Published by: Kowsar

Epstein-Barr Virus Infection and Risk of Breast Cancer: An Adaptive Meta-Analysis for Case-Control Studies

Jong-Myon Bae 1 , * and Eun Hee Kim 1
Authors Information
1 Department of Preventive Medicine, Jeju National University School of Medicine, Jeju-do, Korea
Article information
  • Archives of Clinical Infectious Diseases: July 01, 2016, 11 (3); e34806
  • Published Online: June 11, 2016
  • Article Type: Review Article
  • Received: November 18, 2015
  • Revised: May 1, 2016
  • Accepted: May 2, 2016
  • DOI: 10.5812/archcid.34806

To Cite: Bae J, Kim E H. Epstein-Barr Virus Infection and Risk of Breast Cancer: An Adaptive Meta-Analysis for Case-Control Studies, Arch Clin Infect Dis. 2016 ; 11(3):e34806. doi: 10.5812/archcid.34806.

Copyright © 2016, Infectious Diseases and Tropical Medicine Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Objectives
3. Data Sources
4. Study Selection
5. Data Extraction and Analysis
6. Results
7. Discussion
  • 1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015; 65(2): 87-108[DOI][PubMed]
  • 2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011; 61(2): 69-90[DOI][PubMed]
  • 3. Curado MP. Breast cancer in the world: incidence and mortality. Salud Publica Mex. 2011; 53(5): 372-84[PubMed]
  • 4. Dumitrescu RG, Cotarla I. Understanding breast cancer risk -- where do we stand in 2005? J Cell Mol Med. 2005; 9(1): 208-21[PubMed]
  • 5. Glaser SL, Hsu JL, Gulley ML. Epstein-Barr virus and breast cancer: state of the evidence for viral carcinogenesis. Cancer Epidemiol Biomarkers Prev. 2004; 13(5): 688-97[PubMed]
  • 6. Wong M, Pagano JS, Schiller JT, Tevethia SS, Raab-Traub N, Gruber J. New associations of human papillomavirus, Simian virus 40, and Epstein-Barr virus with human cancer. J Natl Cancer Inst. 2002; 94(24): 1832-6[PubMed]
  • 7. Javier RT, Butel JS. The history of tumor virology. Cancer Res. 2008; 68(19): 7693-706[DOI][PubMed]
  • 8. Epstein-Barr Virus. IARC Monographs-100B.
  • 9. Murray PG, Young LS. The Role of the Epstein-Barr virus in human disease. Front Biosci. 2002; 7-40[PubMed]
  • 10. Hsu JL, Glaser SL. Epstein–Barr virus-associated malignancies: epidemiologic patterns and etiologic implications. Critical Revi Oncol Hematol. 2000; 34(1): 27-53
  • 11. Labrecque LG, Barnes DM, Fentiman IS, Griffin BE. Epstein-Barr virus in epithelial cell tumors: a breast cancer study. Cancer Res. 1995; 55(1): 39-45[PubMed]
  • 12. Amarante MK, Watanabe MA. The possible involvement of virus in breast cancer. J Cancer Res Clin Oncol. 2009; 135(3): 329-37[DOI][PubMed]
  • 13. De Paoli P, Carbone A. Carcinogenic viruses and solid cancers without sufficient evidence of causal association. Int J Cancer. 2013; 133(7): 1517-29[DOI][PubMed]
  • 14. Joshi D, Buehring GC. Are viruses associated with human breast cancer? Scrutinizing the molecular evidence. Breast Cancer Res Treat. 2012; 135(1): 1-15[DOI][PubMed]
  • 15. Liang W, Tian H. Hypothetic association between human papillomavirus infection and breast carcinoma. Med Hypotheses. 2008; 70(2): 305-7[DOI][PubMed]
  • 16. Engels EA, Wacholder S, Katki HA, Chaturvedi AK. Tumor-based case-control studies of infection and cancer: muddling the when and where of molecular epidemiology. Cancer Epidemiol Biomarkers Prev. 2014; 23(10): 1959-64[DOI][PubMed]
  • 17. Huo Q, Zhang N, Yang Q. Epstein-Barr virus infection and sporadic breast cancer risk: a meta-analysis. PLoS One. 2012; 7(2): 31656[DOI][PubMed]
  • 18. Tsai JH, Tsai CH, Cheng MH, Lin SJ, Xu FL, Yang CC. Association of viral factors with non-familial breast cancer in Taiwan by comparison with non-cancerous, fibroadenoma, and thyroid tumor tissues. J Med Virol. 2005; 75(2): 276-81[DOI][PubMed]
  • 19. Preciado MV. Lack of evidence for an association of Epstein–Barr virus infection with breast carcinoma-another point of view. Breast Cancer Res. 2003; 5(4)
  • 20. Preciado MV, Chabay PA, De Matteo EN, Gonzalez P, Grinstein S, Actis A, et al. Epstein-Barr virus in breast carcinoma in Argentina. Arch Pathol Lab Med. 2005; 129(3): 377-81[DOI][PubMed]
  • 21. Bae JM, Kim EH. Citation Discovery Tools for Conducting Adaptive Meta-analyses to Update Systematic Reviews. J Prev Med Public Health. 2016; 49(2): 129-33[DOI][PubMed]
  • 22. Bae JM, Kim EH. Epstein-Barr Virus and Gastric Cancer Risk: A Meta-analysis With Meta-regression of Case-control Studies. J Prev Med Public Health. 2016; 49(2): 97-107[DOI][PubMed]
  • 23. Bae JM, Kim EH. Human papillomavirus infection and risk of breast cancer: a meta-analysis of case-control studies. Infect Agent Cancer. 2016; 11: 14[DOI][PubMed]
  • 24. Harbord RM, Egger M, Sterne JA. A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med. 2006; 25(20): 3443-57[DOI][PubMed]
  • 25. Chang KL, Chen YY, Shibata D, Weiss LM. Description of an in situ hybridization methodology for detection of Epstein-Barr virus RNA in paraffin-embedded tissues, with a survey of normal and neoplastic tissues. Diagn Mol Pathol. 1992; 1(4): 246-55[PubMed]
  • 26. Kadivar M, Monabati A, Joulaee A, Hosseini N. Epstein-Barr virus and breast cancer: lack of evidence for an association in Iranian women. Pathol Oncol Res. 2011; 17(3): 489-92[DOI][PubMed]
  • 27. Perrigoue JG, den Boon JA, Friedl A, Newton MA, Ahlquist P, Sugden B. Lack of association between EBV and breast carcinoma. Cancer Epidemiol Biomarkers Prev. 2005; 14(4): 809-14[DOI][PubMed]
  • 28. Cox B, Richardson A, Graham P, Gislefoss RE, Jellum E, Rollag H. Breast cancer, cytomegalovirus and Epstein-Barr virus: a nested case-control study. Br J Cancer. 2010; 102(11): 1665-9[DOI][PubMed]
  • 29. He JR, Tang LY, Yu DD, Su FX, Song EW, Lin Y, et al. Epstein-Barr virus and breast cancer: serological study in a high-incidence area of nasopharyngeal carcinoma. Cancer Lett. 2011; 309(2): 128-36[DOI][PubMed]
  • 30. He JR, Chen LJ, Su Y, Cen YL, Tang LY, Yu DD, et al. Joint effects of Epstein-Barr virus and polymorphisms in interleukin-10 and interferon-gamma on breast cancer risk. J Infect Dis. 2012; 205(1): 64-71[DOI][PubMed]
  • 31. Qi ML, Xi J, Chen LJ, Su Y, Cen YL, Su FX, et al. Association of Epstein-Barr virus and passive smoking with the risk of breast cancer among Chinese women. Eur J Cancer Prev. 2014; 23(5): 405-11[DOI][PubMed]
  • 32. Viljoen J, Tuaillon E, Nagot N, Danaviah S, Peries M, Padayachee P, et al. Cytomegalovirus, and possibly Epstein-Barr virus, shedding in breast milk is associated with HIV-1 transmission by breastfeeding. AIDS. 2015; 29(2): 145-53[DOI][PubMed]
  • 33. Glenn WK, Whitaker NJ, Lawson JS. High risk human papillomavirus and Epstein Barr virus in human breast milk. BMC Res Notes. 2012; 5: 477[DOI][PubMed]
  • 34. Mohammadizadeh F, Zarean M, Abbasi M. Association of Epstein-Barr virus with invasive breast carcinoma and its impact on well-known clinicopathologic parameters in Iranian women. Adv Biomed Res. 2014; 3: 141[DOI][PubMed]
  • 35. Joshi D, Quadri M, Gangane N, Joshi R, Gangane N. Association of Epstein Barr virus infection (EBV) with breast cancer in rural Indian women. PLoS One. 2009; 4(12): 8180[DOI][PubMed]
  • 36. Luqmani YA, Shousha S. Presence of Epstein-Barr-Virus in Breast-Carcinoma. Int J Oncol. 1995; [DOI]
  • 37. Bonnet M, Guinebretiere JM, Kremmer E, Grunewald V, Benhamou E, Contesso G, et al. Detection of Epstein-Barr virus in invasive breast cancers. J Natl Cancer Inst. 1999; 91(16): 1376-81[PubMed]
  • 38. Fina F, Romain S, Ouafik LH, Palmari J, Ayed FB, Benharkat S, et al. Frequency and genome load of Epstein–Barr virus in 509 breast cancers from different geographical areas. British J Cancer. 2001; 84(6): 783-90[DOI]
  • 39. McCall SA, Lichy JH, Bijwaard KE, Aguilera NS, Chu WS, Taubenberger JK. Epstein-Barr virus detection in ductal carcinoma of the breast. J Natl Cancer Inst. 2001; 93(2): 148-50[PubMed]
  • 40. Grinstein S, Preciado MV, Gattuso P, Chabay PA, Warren WH, De Matteo E, et al. Demonstration of Epstein-Barr virus in carcinomas of various sites. Cancer Res. 2002; 62(17): 4876-8[PubMed]
  • 41. Huang J, Chen H, Hutt-Fletcher L, Ambinder RF, Hayward SD. Lytic viral replication as a contributor to the detection of Epstein-Barr virus in breast cancer. J Virol. 2003; 77(24): 13267-74[PubMed]
  • 42. Kalkan A, Ozdarendeli A, Bulut Y, Yekeler H, Cobanoglu B, Doymaz MZ. Investigation of Epstein-Barr virus DNA in formalin-fixed and paraffin- embedded breast cancer tissues. Med Princ Pract. 2005; 14(4): 268-71[DOI][PubMed]
  • 43. Mohamed WS, Mohamed MA, Omar MM. Possible involvement of Epstein-barr Virus (EBV) in pathogenesis and prognosis of female breast infiltrating duct carcinoma: clinicopathological, immunohistochemical and molecular study. The Egy J Med Microbiol. 2007; 16(2): 403-14
  • 44. Fawzy S, Sallam M, Awad NM. Detection of Epstein-Barr virus in breast carcinoma in Egyptian women. Clin Biochem. 2008; 41(7-8): 486-92[DOI][PubMed]
  • 45. Lorenzetti MA, De Matteo E, Gass H, Martinez Vazquez P, Lara J, Gonzalez P, et al. Characterization of Epstein Barr virus latency pattern in Argentine breast carcinoma. PLoS One. 2010; 5(10): 13603[DOI][PubMed]
  • 46. Hachana M, Amara K, Ziadi S, Romdhane E, Gacem RB, Trimeche M. Investigation of Epstein-Barr virus in breast carcinomas in Tunisia. Pathol Res Pract. 2011; 207(11): 695-700[DOI][PubMed]
  • 47. Mazouni C, Fina F, Romain S, Ouafik L, Bonnier P, Brandone JM, et al. Epstein-Barr virus as a marker of biological aggressiveness in breast cancer. Br J Cancer. 2011; 104(2): 332-7[DOI][PubMed]
  • 48. Glenn WK, Heng B, Delprado W, Iacopetta B, Whitaker NJ, Lawson JS. Epstein-Barr virus, human papillomavirus and mouse mammary tumour virus as multiple viruses in breast cancer. PLoS One. 2012; 7(11): 48788[DOI][PubMed]
  • 49. Khabaz MN. Association of Epstein-Barr virus infection and breast carcinoma. Arch Med Sci. 2013; 9(4): 745-51[DOI][PubMed]
  • 50. Zekri AR, Bahnassy AA, Mohamed WS, El-Kassem FA, El-Khalidi SJ, Hafez MM, et al. Epstein-Barr virus and breast cancer: epidemiological and molecular study on Egyptian and Iraqi women. J Egypt Natl Canc Inst. 2012; 24(3): 123-31[DOI][PubMed]
  • 51. Morales-Sanchez A, Molina-Munoz T, Martinez-Lopez JL, Hernandez-Sancen P, Mantilla A, Leal YA, et al. No association between Epstein-Barr Virus and Mouse Mammary Tumor Virus with breast cancer in Mexican women. Sci Rep. 2013; 3: 2970[DOI][PubMed]
  • 52. Yahia ZA, Adam AA, Elgizouli M, Hussein A, Masri MA, Kamal M, et al. Epstein Barr virus: a prime candidate of breast cancer aetiology in Sudanese patients. Infect Agent Cancer. 2014; 9(1): 9[DOI][PubMed]
  • 53. Richardson AK, Currie MJ, Robinson BA, Morrin H, Phung Y, Pearson JF, et al. Cytomegal Epstein-Barr Virus Breast Cancer. PLoS One. 2015; 10(2): 118989[DOI][PubMed]
  • 54. Wang T, Chang P, Wang L, Yao Q, Guo W, Chen J, et al. The role of human papillomavirus infection in breast cancer. Med Oncol. 2012; 29(1): 48-55[DOI][PubMed]
  • 55. Li J, Ding J, Zhai K. Detection of Human Papillomavirus DNA in Patients with Breast Tumor in China. PLoS One. 2015; 10(8): 136050[DOI][PubMed]
  • 56. Cedro-Tanda A, Cordova-Solis A, Juarez-Cedillo T, Pina-Jimenez E, Hernandez-Caballero ME, Moctezuma-Meza C, et al. Prevalence of HMTV in breast carcinomas and unaffected tissue from Mexican women. BMC Cancer. 2014; 14: 942[DOI][PubMed]
  • 57. Gulley ML. Molecular Diagnosis of Epstein-Barr Virus-Related Diseases. J Molecul Diagnost. 2001; 3(1): 1-10[DOI]
  • 58. Lawson JS, Heng B. Viruses and breast cancer. Cancers (Basel). 2010; 2(2): 752-72[DOI][PubMed]
  • 59. Bae JM. Two hypotheses of dense breasts and viral infection for explaining incidence of breast cancer by age group in Korean women. Epidemiol Health. 2014; 36[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments